Showing 3081-3100 of 8668 for: Cochrane Systematic Reviews Back
- Guided tissue regeneration for periodontal infra-bony defects
Cochrane Systematic Reviews, 29-May-2019
Conventional treatment of destructive periodontal (gum) disease arrests the disease but does not usually regain the bone support or connective tissue lost in the disease process. Guided tissue regeneration (GTR) is a surgical procedure that specifically a
- Guidelines in professions allied to medicine
Cochrane Systematic Reviews, 11-Nov-2008
Clinical practice guidelines aim to reduce inappropriate variations in practice and to promote the delivery of evidence-based health care.
- Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
Cochrane Systematic Reviews, 5-Nov-2012
Cannulation techniques have been recognized to be important in causing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). However, considerable controversy exists about the usefulness of the guidewire-assisted cannulation techn
- H1‐antihistamines for chronic spontaneous urticaria
Cochrane Systematic Reviews, 14-Nov-2014
Chronic spontaneous urticaria (CSU) is characterised by the development of crops of red, itchy, raised weals or hives with no identifiable external cause.
- H1‐antihistamines for the treatment of anaphylaxis with and without shock
Cochrane Systematic Reviews, 24-Jan-2007
Anaphylaxis is an acute systemic allergic reaction, which can be life-threatening. H1-antihistamines are commonly used as an adjuvant therapy in the treatment of anaphylaxis.
- Habit retraining for the management of urinary incontinence in adults
Cochrane Systematic Reviews, 6-Sep-2009
Habit retraining is a form of toileting assistance given by a caregiver to adults with urinary incontinence. It involves the identification of an incontinent person's natural voiding pattern and the development of an individualised toileting schedule, whi
- Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum
Cochrane Systematic Reviews, 16-May-2012
Disseminated intravascular coagulation (DIC) is an acquired syndrome characterised by systemic intravascular activation of coagulation. There are several obstetric causes of DIC during pregnancy and postpartum.
- Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease
Cochrane Systematic Reviews, 14-May-2015
Convective dialysis modalities (haemofiltration (HF), haemodiafiltration (HDF), and acetate-free biofiltration (AFB)) removed excess body fluid across the dialysis membrane with positive pressure and accumulated middle- and larger-size accumulated solutes
- Haemodilution for acute ischaemic stroke
Cochrane Systematic Reviews, 27-Aug-2014
Ischaemic stroke interrupts the flow of blood to part of the brain. Haemodilution is thought to improve the flow of blood to the affected areas of the brain and thus reduce infarct size.
- Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
Cochrane Systematic Reviews, 13-Jan-2010
Anaemia affects 60% to 80% of patients with chronic kidney disease (CKD) reduces quality of life and is a risk factor for early death. Treatment options are blood transfusion, erythropoietin (EPO) and darbepoetin alfa. Recently higher haemoglobin (Hb) and
- Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Jun-2017
Chronic bronchitis and chronic obstructive pulmonary disease (COPD) are serious conditions in which patients are predisposed to viral and bacterial infections resulting in potentially fatal acute exacerbations. Chronic obstructive pulmonary disease is def
- Haemostatic drugs for traumatic brain injury
Cochrane Systematic Reviews, 13-May-2015
Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial bleeding is a common complication of TBI, and intracranial bleeding can develop or worsen after hospital admission. Haemostatic drugs may reduce the occurrence or size o
- Haemostatic therapies for acute spontaneous intracerebral haemorrhage
Cochrane Systematic Reviews, 17-Apr-2018
Outcome after spontaneous (non-traumatic) intracerebral haemorrhage (ICH) is influenced by haematoma volume; up to one-third of ICHs enlarge within 24 hours of onset. Early haemostatic therapy might improve outcome by limiting haematoma growth. This is an
- Haloperidol alone or in combination for acute mania
Cochrane Systematic Reviews, 12-May-2009
The main objectives in treating mania are to control dangerous behaviour, reduce suicide, produce appropriate acute sedation and shorten the episode of mood disturbance. Among different drugs, haloperidol has for many years been used in treating psychotic
- Haloperidol discontinuation for people with schizophrenia
Cochrane Systematic Reviews, 21-Apr-2019
Schizophrenia is a disabling serious mental illness that can be chronic. Haloperidol, one of the first generation of antipsychotic drugs, is effective in the treatment of schizophrenia but can have adverse side effects. The effects of stopping haloperidol
- Haloperidol dose for the acute phase of schizophrenia
Cochrane Systematic Reviews, 7-Aug-2013
Haloperidol is a benchmark, accessible antipsychotic drug against which the effects of newer treatments are gauged.
- Haloperidol for agitation in dementia
Cochrane Systematic Reviews, 12-Apr-2012
Agitation occurs in up to 70% of demented patients. Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear. Previous meta-analyses examined only English language publications or compared haloperidol w
- Haloperidol for long‐term aggression in psychosis
Cochrane Systematic Reviews, 27-Nov-2016
Psychotic disorders can lead some people to become agitated. Characterised by restlessness, excitability and irritability, this can result in verbal and physically aggressive behaviour - and both can be prolonged. Aggression within the psychiatric setting
- Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation)
Cochrane Systematic Reviews, 31-Jul-2017
Haloperidol used alone is recommended to help calm situations of aggression or agitation for people with psychosis. It is widely accessible and may be the only antipsychotic medication available in limited-resource areas.
- Haloperidol for the treatment of nausea and vomiting in palliative care patients
Cochrane Systematic Reviews, 2-Nov-2015
Nausea and vomiting are common symptoms in patients with terminal, incurable illnesses. Both nausea and vomiting can be distressing. Haloperidol is commonly prescribed to relieve these symptoms. This is an updated version of the original Cochrane review p
